@article{oai:repo.qst.go.jp:00080208,
 author = {Murakami, Motohiro and Ishikawa, Hitoshi and Shimizu, Shosei and Iwata, Hiromitsu and Okimoto, Tomoaki and Takagi, Masaru and Murayama, Shigeyuki and Akimoto, Tetsuo and Wada, Hitoshi and Arimura, Takeshi and Sato, Yoshitaka and Gosho, Masahiko and Nakamura, Katsumasa and Sakurai, Hideyuki and Ishikawa, Hitoshi and Iwata, Hiromitsu and Okimoto, Tomoaki and Murayama, Shigeyuki and Akimoto, Tetsuo and Satou, Yoshitaka and Nakamura, Katsumasa and Sakurai, Hideyuki},
 issue = {6},
 journal = {Cancers},
 month = {Jun},
 note = {Androgen deprivation therapy (ADT) combined with radiation therapy benefits intermediate- and high-risk prostate cancer (PC) patients. The optimal ADT duration in combination with high-dose proton beam therapy (PBT) remains unknown.},
 title = {Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group.},
 volume = {12},
 year = {2020}
}